Tirzepatide may help lower blood pressure in adults with obesity
top of page
Browse by category
Search
Tirzepatide significantly lowered the systolic blood for nearly 500 adults with obesity who took the medication for about eight months,...
Disrupted cellular function of “cleaning cells” may explain why some people with obesity develop T2DM
Disrupted function of “cleaning cells” in the body may help to explain why some people with obesity develop type 2 diabetes, while others...
NeuroBo Pharmaceuticals to initiate Phase 1 Clinical Trial of DA-1726 for obesity
The FDA has cleared NeuroBo Pharmaceuticals’ Investigational New Drug (IND) application for DA-1726, a novel, dual oxyntomodulin (OXM)...
Top 10 most read articles on Bariatric News in January 2024
It was another busy month reporting the latest bariatric and metabolic, and obesity-related disease news. We hope we have brought you the...
NLRP3-mediated inflammation leads to insulin resistance and type 2 diabetes
NLRP3 activation is associated with a pathologic inflammatory response in children with obesity and with insulin resistance increasing...
FDA reviewing ProSomnus’ EVO medical device for severe OSA
The FDA has accepted, and is in the process of reviewing, the ProSomnus’ premarket notification for its ProSomnus EVO precision medical...
Obesity Bill of Rights to define quality obesity care as the right of all adults
The National Consumers League (NCL) and National Council on Aging (NCOA) in the US have introduced the nation's first Obesity Bill of...
Browse by tag
bottom of page